Hotline: +86-18022463983    020-85206863

Synthetic Viral Controls - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: 2024-10-03   |   Pages: 121   |   Tables: 207   |  New Technology

Controls based on viral nucleic acids extracted from either an infected patient or from live virus propagated in cell culture have safety and security concerns.
The global market for Synthetic Viral Controls was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Synthetic Viral Controls was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Synthetic Viral Controls was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Synthetic Viral Controls was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Synthetic Viral Controls include Twist Bioscience, Vector Biolabs, Premade Lentivirus Particles, Telesis Bio, Thermo Fisher Scientific, Sigma Aldrich, Antibody Engineering, Amyris and Precigen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Viral Controls, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Synthetic Viral Controls by region & country, by Type, and by Application.
The Synthetic Viral Controls market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Viral Controls.
Market Segmentation
By Company
Twist Bioscience
Vector Biolabs
Premade Lentivirus Particles
Telesis Bio
Thermo Fisher Scientific
Sigma Aldrich
Antibody Engineering
Amyris
Precigen
Ginkgo Bioworks
Codexis
Impossible Foods
National Resilience
ElevateBio
Insitro
Apeel Sciences
Segment by Type:
Monkeypox Controls
SARS-COV-2 CONTROLS
Respiratory Virus Controls
Segment by Application
Child
Teenager
Youth
Middle-Aged
Elder
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Synthetic Viral Controls manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Synthetic Viral Controls in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Synthetic Viral Controls in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Market Overview
1.1 Synthetic Viral Controls Product Introduction
1.2 Global Synthetic Viral Controls Market Size Forecast
1.3 Synthetic Viral Controls Market Trends & Drivers
1.3.1 Synthetic Viral Controls Industry Trends
1.3.2 Synthetic Viral Controls Market Drivers & Opportunity
1.3.3 Synthetic Viral Controls Market Challenges
1.3.4 Synthetic Viral Controls Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Synthetic Viral Controls Players Revenue Ranking (2023)
2.2 Global Synthetic Viral Controls Revenue by Company (2019-2024)
2.3 Key Companies Synthetic Viral Controls Manufacturing Base Distribution and Headquarters
2.4 Key Companies Synthetic Viral Controls Product Offered
2.5 Key Companies Time to Begin Mass Production of Synthetic Viral Controls
2.6 Synthetic Viral Controls Market Competitive Analysis
2.6.1 Synthetic Viral Controls Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Synthetic Viral Controls Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Viral Controls as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monkeypox Controls
3.1.2 SARS-COV-2 CONTROLS
3.1.3 Respiratory Virus Controls
3.2 Global Synthetic Viral Controls Sales Value by Type
3.2.1 Global Synthetic Viral Controls Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Synthetic Viral Controls Sales Value, by Type (2019-2030)
3.2.3 Global Synthetic Viral Controls Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Child
4.1.2 Teenager
4.1.3 Youth
4.1.4 Middle-Aged
4.1.5 Elder
4.1.6 Others
4.2 Global Synthetic Viral Controls Sales Value by Application
4.2.1 Global Synthetic Viral Controls Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Synthetic Viral Controls Sales Value, by Application (2019-2030)
4.2.3 Global Synthetic Viral Controls Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Synthetic Viral Controls Sales Value by Region
5.1.1 Global Synthetic Viral Controls Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Synthetic Viral Controls Sales Value by Region (2019-2024)
5.1.3 Global Synthetic Viral Controls Sales Value by Region (2025-2030)
5.1.4 Global Synthetic Viral Controls Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Synthetic Viral Controls Sales Value, 2019-2030
5.2.2 North America Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Synthetic Viral Controls Sales Value, 2019-2030
5.3.2 Europe Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Synthetic Viral Controls Sales Value, 2019-2030
5.4.2 Asia Pacific Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Synthetic Viral Controls Sales Value, 2019-2030
5.5.2 South America Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Synthetic Viral Controls Sales Value, 2019-2030
5.6.2 Middle East & Africa Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Synthetic Viral Controls Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Synthetic Viral Controls Sales Value
6.3 United States
6.3.1 United States Synthetic Viral Controls Sales Value, 2019-2030
6.3.2 United States Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Synthetic Viral Controls Sales Value, 2019-2030
6.4.2 Europe Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Synthetic Viral Controls Sales Value, 2019-2030
6.5.2 China Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.5.3 China Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Synthetic Viral Controls Sales Value, 2019-2030
6.6.2 Japan Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Synthetic Viral Controls Sales Value, 2019-2030
6.7.2 South Korea Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Synthetic Viral Controls Sales Value, 2019-2030
6.8.2 Southeast Asia Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Synthetic Viral Controls Sales Value, 2019-2030
6.9.2 India Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.9.3 India Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Twist Bioscience
7.1.1 Twist Bioscience Profile
7.1.2 Twist Bioscience Main Business
7.1.3 Twist Bioscience Synthetic Viral Controls Products, Services and Solutions
7.1.4 Twist Bioscience Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.1.5 Twist Bioscience Recent Developments
7.2 Vector Biolabs
7.2.1 Vector Biolabs Profile
7.2.2 Vector Biolabs Main Business
7.2.3 Vector Biolabs Synthetic Viral Controls Products, Services and Solutions
7.2.4 Vector Biolabs Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.2.5 Vector Biolabs Recent Developments
7.3 Premade Lentivirus Particles
7.3.1 Premade Lentivirus Particles Profile
7.3.2 Premade Lentivirus Particles Main Business
7.3.3 Premade Lentivirus Particles Synthetic Viral Controls Products, Services and Solutions
7.3.4 Premade Lentivirus Particles Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.3.5 Telesis Bio Recent Developments
7.4 Telesis Bio
7.4.1 Telesis Bio Profile
7.4.2 Telesis Bio Main Business
7.4.3 Telesis Bio Synthetic Viral Controls Products, Services and Solutions
7.4.4 Telesis Bio Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.4.5 Telesis Bio Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Synthetic Viral Controls Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 Sigma Aldrich
7.6.1 Sigma Aldrich Profile
7.6.2 Sigma Aldrich Main Business
7.6.3 Sigma Aldrich Synthetic Viral Controls Products, Services and Solutions
7.6.4 Sigma Aldrich Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.6.5 Sigma Aldrich Recent Developments
7.7 Antibody Engineering
7.7.1 Antibody Engineering Profile
7.7.2 Antibody Engineering Main Business
7.7.3 Antibody Engineering Synthetic Viral Controls Products, Services and Solutions
7.7.4 Antibody Engineering Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.7.5 Antibody Engineering Recent Developments
7.8 Amyris
7.8.1 Amyris Profile
7.8.2 Amyris Main Business
7.8.3 Amyris Synthetic Viral Controls Products, Services and Solutions
7.8.4 Amyris Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.8.5 Amyris Recent Developments
7.9 Precigen
7.9.1 Precigen Profile
7.9.2 Precigen Main Business
7.9.3 Precigen Synthetic Viral Controls Products, Services and Solutions
7.9.4 Precigen Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.9.5 Precigen Recent Developments
7.10 Ginkgo Bioworks
7.10.1 Ginkgo Bioworks Profile
7.10.2 Ginkgo Bioworks Main Business
7.10.3 Ginkgo Bioworks Synthetic Viral Controls Products, Services and Solutions
7.10.4 Ginkgo Bioworks Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.10.5 Ginkgo Bioworks Recent Developments
7.11 Codexis
7.11.1 Codexis Profile
7.11.2 Codexis Main Business
7.11.3 Codexis Synthetic Viral Controls Products, Services and Solutions
7.11.4 Codexis Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.11.5 Codexis Recent Developments
7.12 Impossible Foods
7.12.1 Impossible Foods Profile
7.12.2 Impossible Foods Main Business
7.12.3 Impossible Foods Synthetic Viral Controls Products, Services and Solutions
7.12.4 Impossible Foods Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.12.5 Impossible Foods Recent Developments
7.13 National Resilience
7.13.1 National Resilience Profile
7.13.2 National Resilience Main Business
7.13.3 National Resilience Synthetic Viral Controls Products, Services and Solutions
7.13.4 National Resilience Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.13.5 National Resilience Recent Developments
7.14 ElevateBio
7.14.1 ElevateBio Profile
7.14.2 ElevateBio Main Business
7.14.3 ElevateBio Synthetic Viral Controls Products, Services and Solutions
7.14.4 ElevateBio Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.14.5 ElevateBio Recent Developments
7.15 Insitro
7.15.1 Insitro Profile
7.15.2 Insitro Main Business
7.15.3 Insitro Synthetic Viral Controls Products, Services and Solutions
7.15.4 Insitro Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.15.5 Insitro Recent Developments
7.16 Apeel Sciences
7.16.1 Apeel Sciences Profile
7.16.2 Apeel Sciences Main Business
7.16.3 Apeel Sciences Synthetic Viral Controls Products, Services and Solutions
7.16.4 Apeel Sciences Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.16.5 Apeel Sciences Recent Developments
8 Industry Chain Analysis
8.1 Synthetic Viral Controls Industrial Chain
8.2 Synthetic Viral Controls Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Synthetic Viral Controls Sales Model
8.5.2 Sales Channel
8.5.3 Synthetic Viral Controls Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Synthetic Viral Controls Market Trends
Table 2. Synthetic Viral Controls Market Drivers & Opportunity
Table 3. Synthetic Viral Controls Market Challenges
Table 4. Synthetic Viral Controls Market Restraints
Table 5. Global Synthetic Viral Controls Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Synthetic Viral Controls Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Synthetic Viral Controls Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Synthetic Viral Controls Product Type
Table 9. Key Companies Time to Begin Mass Production of Synthetic Viral Controls
Table 10. Global Synthetic Viral Controls Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Viral Controls as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Synthetic Viral Controls Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Synthetic Viral Controls Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Synthetic Viral Controls Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Synthetic Viral Controls Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Synthetic Viral Controls Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Synthetic Viral Controls Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Synthetic Viral Controls Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Synthetic Viral Controls Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Synthetic Viral Controls Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Synthetic Viral Controls Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Synthetic Viral Controls Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Synthetic Viral Controls Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Synthetic Viral Controls Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Synthetic Viral Controls Sales Value by Region (2019-2024) & (%)
Table 27. Global Synthetic Viral Controls Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Synthetic Viral Controls Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Synthetic Viral Controls Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Synthetic Viral Controls Sales Value, (2025-2030) & (US$ Million)
Table 31. Twist Bioscience Basic Information List
Table 32. Twist Bioscience Description and Business Overview
Table 33. Twist Bioscience Synthetic Viral Controls Products, Services and Solutions
Table 34. Revenue (US$ Million) in Synthetic Viral Controls Business of Twist Bioscience (2019-2024)
Table 35. Twist Bioscience Recent Developments
Table 36. Vector Biolabs Basic Information List
Table 37. Vector Biolabs Description and Business Overview
Table 38. Vector Biolabs Synthetic Viral Controls Products, Services and Solutions
Table 39. Revenue (US$ Million) in Synthetic Viral Controls Business of Vector Biolabs (2019-2024)
Table 40. Vector Biolabs Recent Developments
Table 41. Premade Lentivirus Particles Basic Information List
Table 42. Premade Lentivirus Particles Description and Business Overview
Table 43. Premade Lentivirus Particles Synthetic Viral Controls Products, Services and Solutions
Table 44. Revenue (US$ Million) in Synthetic Viral Controls Business of Premade Lentivirus Particles (2019-2024)
Table 45. Premade Lentivirus Particles Recent Developments
Table 46. Telesis Bio Basic Information List
Table 47. Telesis Bio Description and Business Overview
Table 48. Telesis Bio Synthetic Viral Controls Products, Services and Solutions
Table 49. Revenue (US$ Million) in Synthetic Viral Controls Business of Telesis Bio (2019-2024)
Table 50. Telesis Bio Recent Developments
Table 51. Thermo Fisher Scientific Basic Information List
Table 52. Thermo Fisher Scientific Description and Business Overview
Table 53. Thermo Fisher Scientific Synthetic Viral Controls Products, Services and Solutions
Table 54. Revenue (US$ Million) in Synthetic Viral Controls Business of Thermo Fisher Scientific (2019-2024)
Table 55. Thermo Fisher Scientific Recent Developments
Table 56. Sigma Aldrich Basic Information List
Table 57. Sigma Aldrich Description and Business Overview
Table 58. Sigma Aldrich Synthetic Viral Controls Products, Services and Solutions
Table 59. Revenue (US$ Million) in Synthetic Viral Controls Business of Sigma Aldrich (2019-2024)
Table 60. Sigma Aldrich Recent Developments
Table 61. Antibody Engineering Basic Information List
Table 62. Antibody Engineering Description and Business Overview
Table 63. Antibody Engineering Synthetic Viral Controls Products, Services and Solutions
Table 64. Revenue (US$ Million) in Synthetic Viral Controls Business of Antibody Engineering (2019-2024)
Table 65. Antibody Engineering Recent Developments
Table 66. Amyris Basic Information List
Table 67. Amyris Description and Business Overview
Table 68. Amyris Synthetic Viral Controls Products, Services and Solutions
Table 69. Revenue (US$ Million) in Synthetic Viral Controls Business of Amyris (2019-2024)
Table 70. Amyris Recent Developments
Table 71. Precigen Basic Information List
Table 72. Precigen Description and Business Overview
Table 73. Precigen Synthetic Viral Controls Products, Services and Solutions
Table 74. Revenue (US$ Million) in Synthetic Viral Controls Business of Precigen (2019-2024)
Table 75. Precigen Recent Developments
Table 76. Ginkgo Bioworks Basic Information List
Table 77. Ginkgo Bioworks Description and Business Overview
Table 78. Ginkgo Bioworks Synthetic Viral Controls Products, Services and Solutions
Table 79. Revenue (US$ Million) in Synthetic Viral Controls Business of Ginkgo Bioworks (2019-2024)
Table 80. Ginkgo Bioworks Recent Developments
Table 81. Codexis Basic Information List
Table 82. Codexis Description and Business Overview
Table 83. Codexis Synthetic Viral Controls Products, Services and Solutions
Table 84. Revenue (US$ Million) in Synthetic Viral Controls Business of Codexis (2019-2024)
Table 85. Codexis Recent Developments
Table 86. Impossible Foods Basic Information List
Table 87. Impossible Foods Description and Business Overview
Table 88. Impossible Foods Synthetic Viral Controls Products, Services and Solutions
Table 89. Revenue (US$ Million) in Synthetic Viral Controls Business of Impossible Foods (2019-2024)
Table 90. Impossible Foods Recent Developments
Table 91. National Resilience Basic Information List
Table 92. National Resilience Description and Business Overview
Table 93. National Resilience Synthetic Viral Controls Products, Services and Solutions
Table 94. Revenue (US$ Million) in Synthetic Viral Controls Business of National Resilience (2019-2024)
Table 95. National Resilience Recent Developments
Table 96. ElevateBio Basic Information List
Table 97. ElevateBio Description and Business Overview
Table 98. ElevateBio Synthetic Viral Controls Products, Services and Solutions
Table 99. Revenue (US$ Million) in Synthetic Viral Controls Business of ElevateBio (2019-2024)
Table 100. ElevateBio Recent Developments
Table 101. Insitro Basic Information List
Table 102. Insitro Description and Business Overview
Table 103. Insitro Synthetic Viral Controls Products, Services and Solutions
Table 104. Revenue (US$ Million) in Synthetic Viral Controls Business of Insitro (2019-2024)
Table 105. Insitro Recent Developments
Table 106. Apeel Sciences Basic Information List
Table 107. Apeel Sciences Description and Business Overview
Table 108. Apeel Sciences Synthetic Viral Controls Products, Services and Solutions
Table 109. Revenue (US$ Million) in Synthetic Viral Controls Business of Apeel Sciences (2019-2024)
Table 110. Apeel Sciences Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Synthetic Viral Controls Downstream Customers
Table 114. Synthetic Viral Controls Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Synthetic Viral Controls Product Picture
Figure 2. Global Synthetic Viral Controls Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Synthetic Viral Controls Sales Value (2019-2030) & (US$ Million)
Figure 4. Synthetic Viral Controls Report Years Considered
Figure 5. Global Synthetic Viral Controls Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Synthetic Viral Controls Revenue in 2023
Figure 7. Synthetic Viral Controls Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Monkeypox Controls Picture
Figure 9. SARS-COV-2 CONTROLS Picture
Figure 10. Respiratory Virus Controls Picture
Figure 11. Global Synthetic Viral Controls Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Synthetic Viral Controls Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Child
Figure 14. Product Picture of Teenager
Figure 15. Product Picture of Youth
Figure 16. Product Picture of Middle-Aged
Figure 17. Product Picture of Elder
Figure 18. Product Picture of Others
Figure 19. Global Synthetic Viral Controls Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Synthetic Viral Controls Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Synthetic Viral Controls Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Synthetic Viral Controls Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Synthetic Viral Controls Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Synthetic Viral Controls Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Synthetic Viral Controls Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Synthetic Viral Controls Sales Value (%), (2019-2030)
Figure 32. United States Synthetic Viral Controls Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Synthetic Viral Controls Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Synthetic Viral Controls Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Synthetic Viral Controls Sales Value by Application (%), 2023 VS 2030
Figure 38. China Synthetic Viral Controls Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
Figure 40. China Synthetic Viral Controls Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Synthetic Viral Controls Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Synthetic Viral Controls Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Synthetic Viral Controls Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Synthetic Viral Controls Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Synthetic Viral Controls Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Synthetic Viral Controls Sales Value by Application (%), 2023 VS 2030
Figure 50. India Synthetic Viral Controls Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
Figure 52. India Synthetic Viral Controls Sales Value by Application (%), 2023 VS 2030
Figure 53. Synthetic Viral Controls Industrial Chain
Figure 54. Synthetic Viral Controls Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation

Our Clients